Clinical Trial Update: Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Humalog Mix50/50 as a treatment for gestational diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Drugs mentioned

• Humalog Mix50/50 (insulin lispro mix 50/50)

Snippet

Sponsor: Sansum Diabetes Research Institute | Conditions: Gestational Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2022-06-08